Showing results (421-430 of 783) with videos related to

Sort By:
Pageof 79
Journal De Chirurgie|August 1, 1989
[Cyclosporin, toxicity and efficacy in rejection of liver allografts in the rat]A Settaf, J Gugenheim, M K Lahlou, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 1, 1988
One liver for two: an experimental study in primatesD Houssin, C Vigouroux, F Filipponi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 15, 2010
Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factorE Vibert, D Azoulay, E Hoti, et al.
Transplantation|February 1, 1988
Relationship between the liver and lymphocytotoxic alloantibodies in inbred rats. Specific absorption by nonparenchymal liver cellsJ Gugenheim, B Le Thai, P Rouger, et al.
Hepatology (Baltimore, Md.)|April 1, 1995
Deleterious influence of pyrazinamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazidF Durand, J Bernuau, D Pessayre, et al.
Transplantation|April 27, 1995
The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patientsO Farges, A N Kalil, D Samuel, et al.
Gastroenterology|April 1, 1995
Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantationC Féray, M Gigou, D Samuel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
Primary non-Hodgkin's lymphomas of the liver with nodular and diffuse infiltration patterns have different prognosesJ F Emile, D Azoulay, J M Gornet, et al.
Presse Medicale (Paris, France : 1983)|July 1, 1995
[Evaluation of results of liver transplantation: experience based on a series of 1052 transplantations]H Bismuth, O Farges, D Castaing, et al.
The Journal of Infusional Chemotherapy|January 1, 1995
A phase I-II trial of five-day continuous intravenous infusion of 5-fluorouracil delivered at circadian rhythm modulated rate in patients with metastatic colorectal cancerF Lévi, A Soussan, R Adam, et al.
Pageof 79